Press release
Thyroid Cancer Diagnostics Market: Global Size, Share, Growth, Trends, Analysis, Forecast, Outlook 2024-2033 | Mergers and Acquisitions, Top Major Key Players, Competitive Landscape
Thyroid Cancer Diagnostics Market
The thyroid cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to growing demand for companion diagnostics, increasing patient preference for personalized medicine, economic growth and healthcare spending, physician education and training, regulatory approvals and clearances.. Major trends in the forecast period include liquid biopsies, globalization of diagnostic technologies, technological advancements, research and development, integration of artificial intelligence, collaborations and partnerships.
Market Overview -
Thyroid cancer diagnostics refers to a technique to test a lump or nodule responsible for thyroid cancer present in the body and helps in diagnosing thyroid cancer. Thyroid cancer refers to a type of cancer that starts in the thyroid gland when cells begin to grow out of control.
Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12030&type=smp
The Surge In Thyroid Cancer Prevalence And Its Implications On The Diagnostic Market
The increasing prevalence of thyroid cancer is driving the growth of the thyroid cancer diagnostic market going forward. Thyroid cancer is a disease in the thyroid gland (a gland near the base of the throat that produces hormones to help regulate body temperature, heart rate, blood pressure, and weight). Thyroid cancer diagnostics help to discover thyroid cancer by providing early detection that can help improve treatment outcomes. Thus, the increasing prevalence of thyroid cancer increases the demand for the diagnostic market. For instance, in September 2023, according to a report published by the American Cancer Society, a US-based non-profit organization, there are anticipated to be approximately 43,720 new cases of thyroid cancer, with 12,540 occurring in men and 31,180 in women in 2023. The projected number of deaths from thyroid cancer in the same year is around 2,120, with 970 in men and 1,150 in women. Therefore, thyroid cancer's increasing prevalence is propelling the diagnostic market of thyroid cancer.
Competitive Landscape -
Major companies operating in the thyroid cancer diagnostics market report are Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline plc, Canon Inc., Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., GE Healthcare, AstraZeneca plc, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc.
Product Innovations In The Thyroid Cancer Diagnostic Market
Major companies operating in the thyroid cancer diagnostic market are developing innovative products such as oral tablets to meet larger customer bases, more sales, and increase revenue. Oral tablets are solid pharmaceutical dosage forms designed for oral administration. For instance, in September 2021, Exelixis Inc., a US-based biotechnology company, announced the U.S. Food and Drug Administration (FDA) approval for CABOMETYX (cabozantinib). It is indicated for treating differentiated thyroid cancer (DTC) in adults and pediatric patients aged 12 and above who have locally advanced or metastatic disease. This treatment is specifically for cases that have advanced after previous vascular endothelial growth factor receptor (VEGFR)-targeted therapy and where patients are either refractory to radioactive iodine or ineligible for such treatment. CABOMETYX tablets have received approval for multiple indications, including the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma in patients previously treated with sorafenib, first-line treatment for advanced RCC in combination with nivolumab, and the management of locally advanced or metastatic differentiated thyroid cancer (DTC) in adult and pediatric patients aged 12 and older.
Browse Full Report @
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report
Key Segments -
The thyroid cancer diagnostics market covered in this report is segmented -
1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Type
2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users
Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thyroid Cancer Diagnostics Market: Global Size, Share, Growth, Trends, Analysis, Forecast, Outlook 2024-2033 | Mergers and Acquisitions, Top Major Key Players, Competitive Landscape here
News-ID: 3472734 • Views: …
More Releases from The Business research company
Medical Device Contract Manufacturing Global Market Size, Top Companies, Share, …
The medical device contract manufacturing market size has grown rapidly in recent years. It will grow from $88.36 billion in 2023 to $101.04 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to cost efficiency, specialized manufacturing, supply chain resilience, quality and certification, regulatory expertise.
The medical device contract manufacturing market size is expected to…
Maritime Safety System Global Market Exhibit a Remarkable CAGR of 5.2% and is Ex …
The maritime safety system market size has grown strongly in recent years. It will grow from $19.85 billion in 2023 to $21.18 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to international maritime regulations, growth in global shipping, maritime accidents, rising concerns about piracy, environmental protection.
The maritime safety system market size is expected…
Luxury Vinyl Tiles (LVT) Flooring Global Market Size, Growth, Share with Countri …
The luxury vinyl tiles (lvt) flooring market size has grown rapidly in recent years. It will grow from $23 billion in 2023 to $26.36 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to residential renovation boom, commercial flooring solutions, water and moisture resistance, environmental sustainability, health and safety compliance.
The luxury vinyl tiles (lvt)…
Liquid Packaging Global Market Sales Estimated to Hit $681.84 Billion By 2028 | …
The liquid packaging market size has grown strongly in recent years. It will grow from $475.82 billion in 2023 to $507.27 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to beverage industry growth, sustainability initiatives, e-commerce growth, packaging regulations, consumer behavior.
The liquid packaging market size is expected to see strong growth in the…
More Releases for Thyroid
Thyroid Cancer Treatment Market Increasing Ageing Population and Thyroid Cancer …
The thyroid cancer treatment market is projected to grow with a moderate CAGR during the forecast period, i.e., 2021-2029 on account of the increasing healthcare expenditure and the rising prevalence of thyroid cancer. As per The American Society of Clinical Oncology, in 2020, 44,280 number of adults in the United States is estimated to suffer from thyroid cancer. Such increasing prevalence of thyroid cancer is further expected to drive the…
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
The number of patients suffering from thyroid gland disorders across the globe is increasing at a rapid rate. This direct increase in demand is expected to be a primary driver for the development of thyroid gland disorder treatments. The number of patients with thyroid gland disorder is increasing due to a growing population of the elderly, who are prone to thyroid disorders and similar illnesses.
Additionally, a person suffering from…
